Telotristat ethyl

(Xermelo®)

Telotristat ethyl

Drug updated on 11/14/2023

Dosage FormTablet (oral: 250 mg)
Drug ClassTryptophan hydroxylase inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.